Author Correction: Neural and Molecular Changes During Mind-Body Reconceptualization

The original manuscript titled 'Neural and molecular changes during a mind-body reconceptualization' has been updated to correct an error in the reported statistical analysis. The authors acknowledge that the p-values presented in Figure 3 were calculated using a non-parametric test rather than the parametric method initially stated. This correction does not alter the primary findings regarding neural plasticity or molecular markers observed during the intervention period.

The study utilized electroencephalography (EEG) and blood-based biomarkers to assess changes in brain activity and inflammatory markers following a structured mind-body training protocol. Participants were divided into experimental and control groups, with data collection occurring at baseline, post-intervention, and follow-up intervals. The corrected analysis confirms the initial observation of significant group differences in theta wave power and interleukin-6 levels.

No new data or additional experiments were conducted as part of this correction. The authors have revised the methods section to accurately reflect the statistical approach used for all reported outcomes. This ensures transparency regarding the analytical techniques employed during the study design phase. The corrected manuscript maintains the original sample size and participant demographics without modification.

This author correction is intended solely for research use within laboratory settings where peptide synthesis or biological assays may be conducted based on the findings. It does not constitute a clinical recommendation or therapeutic protocol for human application. All data presented herein are derived from controlled experimental conditions and should not be extrapolated to general population health outcomes without further validation.

The corrected version of this manuscript is now available in the journal archive for peer review and citation purposes. Researchers utilizing these findings for laboratory peptide development must adhere to established safety guidelines and institutional review board protocols. Continued monitoring of molecular markers remains essential when applying these results to experimental models.